secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001193125-23-254974
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems implements 1-for-100 reverse stock split; trading begins Oct 13
-----------------------------------------------------------------------------

- Reverse split ratio of 1-for-100 approved by Board on Oct 10, 2023.
- Amendment filed with Delaware Secretary of State on Oct 12, 2023; effective same date.
- Common stock will trade on Nasdaq on split-adjusted basis on Oct 13, 2023 under ticker TTOO.
- No fractional shares; cash payment based on Oct 12 closing price for fractional interests.
- New CUSIP number is 89853L 302.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523254974/0001193125-23-254974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523254974/d468619d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-254974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer